Zobrazeno 1 - 10
of 41
pro vyhledávání: '"L E, Mathes"'
Autor:
Conrad P, Quinn, Carol L, Sabourin, Nancy A, Niemuth, Han, Li, Vera A, Semenova, Thomas L, Rudge, Heather J, Mayfield, Jarad, Schiffer, Robert S, Mittler, Chris C, Ibegbu, Jens, Wrammert, Rafi, Ahmed, April M, Brys, Robert E, Hunt, Denyse, Levesque, James E, Estep, Roy E, Barnewall, David M, Robinson, Brian D, Plikaytis, Nina, Marano, L E, Mathes
Publikováno v:
Clinical and Vaccine Immunology. 19:1730-1745
A 3-dose (0, 1, and 6 months) intramuscular (3-IM) priming series of a human dose (HuAVA) and dilutions of up to 1:10 of anthrax vaccine adsorbed (AVA) provided statistically significant levels of protection (60 to 100%) against inhalation anthrax fo
Publikováno v:
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 9(2)
Prophylactic zidovudine (ZDV) therapy in feline immunodeficiency virus (FIV) inoculated cats was evaluated for 12 months postinfection (pi) and 11 months post drug treatment. Plasma FIV antigenemia was prevented in six of six ZDV-treated and none of
Publikováno v:
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 9(1)
Naturally occurring retroviral infections cause progressive weight loss, immune suppression, invasion by opportunistic organisms, and eventual death. Feline leukemia virus (FeLV) inhibited growth and decreased energy intake in seven experimentally in
Lymphocytotoxic strains of feline leukemia virus induce apoptosis in feline T4-thymic lymphoma cells
Autor:
J L, Rojko, R M, Fulton, L J, Rezanka, L L, Williams, E, Copelan, C M, Cheney, G S, Reichel, J C, Neil, L E, Mathes, T G, Fisher
Publikováno v:
Laboratory investigation; a journal of technical methods and pathology. 66(4)
Feline leukemia retrovirus (FeLV) strains with subgroup C env genes kill feline T4 lymphoma 3201 cells by 7 to 12 days after in vitro inoculation, whereas FeLV strains with subgroup A env genes do not. Neither FeLV-A nor FeLV-C kill feline fibroblast
Publikováno v:
American journal of veterinary research. 53(4)
Anecdotal descriptions of atypical FeLV infections, wherein standard clinical ELISA or immunofluorescence testing fails to detect active infections, suggest that an unknown proportion of FeLV-infected cats may go undetected. In this study, 127 viremi
Publikováno v:
American journal of veterinary research. 52(12)
Phosphonoformate (PFA), a noncompetitive inhibitor of reverse transcriptase (RT), inhibited feline leukemia virus (FeLV) infection of 2 feline cell lines and inhibited progeny virus RT activity in a chronically FeLV-infected cell line. Feline leukemi
Publikováno v:
American journal of veterinary research. 52(11)
Bone marrow fibroblast colony-forming units (CFU-F) were evaluated in cats experimentally infected with different, isolates of FeLV. Cats infected with the Kawakami-Theilen isolate of FeLV (FeLV-KT) had progressive decrease in the number of CFU-F at
Publikováno v:
American journal of veterinary research. 51(3)
Biological effects of staphylococcal protein A (SPA) immunotherapy were studied in 5 viremic and 6 nonviremic cats with induced FeLV infection and in 6 control cats. The SPA therapy neither reversed FeLV viremia nor resulted in consistent improvement
Publikováno v:
The Journal of Immunology. 135:583-590
Murine splenocytes and cloned murine T cells were used to study the in vitro immunosuppressive effects of UV-inactivated feline leukemia virus (FeLV-UV) on lymphokine secretion. FeLV-UV can significantly depress the accumulation of IL 2 in cultures o
Publikováno v:
The Journal of Immunology. 134:3396-3403
Murine splenocytes were used to study the in vitro immunosuppressive effects of UV-inactivated feline leukemia virus (FeLV-UV). FeLV-UV blocks both alloantigen (DBA/2)-induced and Con A-induced proliferation of C57BL/6 splenocytes in a dose-dependent